Quick Answer
RECURSION PHARMACEUTICALS, INC. reported Shares Outstanding of 528.18 million shares for fiscal year 2025.
RECURSION PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 528.18M | +33.1% |
| 2024 | 396.80M | +69.4% |
| 2023 | 234.27M | +22.6% |
| 2022 | 191.02M | +12.2% |
| 2021 | 170.27M | +663.1% |
| 2020 | 22.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 491.80M | +71.9% | +13.6% |
| June 30, 2025 | 432.83M | +54.0% | +6.5% |
| March 31, 2025 | 406.41M | +71.1% | +2.4% |
| December 31, 2024 | 396.80M | +69.4% | +38.7% |
| September 30, 2024 | 286.12M | +32.3% | +1.8% |
| June 30, 2024 | 280.97M | +35.9% | +18.3% |
| March 31, 2024 | 237.51M | +23.6% | +1.4% |
| December 31, 2023 | 234.27M | +22.6% | +8.3% |
- RECURSION PHARMACEUTICALS, INC. showed an increase of +33.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, RECURSION PHARMACEUTICALS, INC.’s shares outstanding has grown by 2267.0% (from 22.31 million shares to 528.18 million shares).
- The most recent figure is from RECURSION PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: